Maiden Pharmaceuticals: India defends cough syrups linked to Gambia child deaths


The letter, dated 13 December, was written by Dr VG Somani, India’s drugs controller general, and addressed to Rogerio Gaspar, director of regulation and prequalification at the WHO. According to Reuters, India’s health ministry released a copy of the letter to reporters on Thursday.


Source link


Leave a Reply

Your email address will not be published. Required fields are marked *